The value of clinical trial data in competitive intelligence

Comment

The value of clinical trial data in competitive intelligence

Understanding what your competitors are working on and how it effects your business is key across most industries.  The clinical trial arena is no different.   Knowing what trials are starting or in progress along with the details of the protocols from past trials can give your company a leg up.  Learn more about the importance of clinical trial information as part of your competitive intelligence plan in our new blog post!

Comment

Clinical trials for Alzheimer’s disease: what next?

Comment

Clinical trials for Alzheimer’s disease: what next?

With this seemingly unrelenting bad news, what does the future hold for drug development for Alzheimer's Disease (AD)? This post provides a brief overview of the landscape of trials for AD and why there is optimism that DMDs for this devastating condition will be a case of when they will be developed not if.

Comment

The Rituximab Gold Rush Continues

Comment

The Rituximab Gold Rush Continues

The Rutuximab patent period is over, and now clinical trial experimentation of the product is available to all industry players, which is creating a huge activity of new trials with the drug. We analyze the data.

Comment